Human Papilloma Virus Vaccine Immunogenicity and Safety Trial in Young Adult Women With GSK Bio's Novel HPV Vaccine.

NCT00231413 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

383

Enrollment

INDUSTRY

Sponsor class

Conditions

Infections, Papillomavirus

Interventions

BIOLOGICAL: HPV 16/18 L1 AS04
BIOLOGICAL: HPV-16/18/31/45 L1 AS04 Formulation 1
BIOLOGICAL: HPV-16/18/31/45 L1 AS04 Formulation 2
BIOLOGICAL: HPV-16/18/31/45 L1 AS04 Formulation 3
BIOLOGICAL: HPV-16/18/31/45 L1 AS04 Formulation 4
BIOLOGICAL: HPV-16/18/31/45 L1 AS04 Formulation 5
BIOLOGICAL: HPV-16/18/31/45 L1 AS04 Formulation 6

Sponsor

GlaxoSmithKline